These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33027796)

  • 1. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Matrix Metalloproteinase-8 and Myeloperoxidase Predict Survival after Resection of Colorectal Liver Metastases.
    Reijonen P; Peltonen R; Tervahartiala T; Sorsa T; Isoniemi H
    Oncology; 2021; 99(12):766-779. PubMed ID: 34571507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
    Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
    BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Behavior of MMP-2, MMP-7, MMP-9, and Their Inhibitors TIMP-1 and TIMP-2 in Adenoma-Colorectal Cancer Sequence.
    Barabás L; Hritz I; István G; Tulassay Z; Herszényi L
    Dig Dis; 2021; 39(3):217-224. PubMed ID: 32961536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How to predict the relapse after surgery or radiofrequency of liver metastases of colorectal cancer? Interest of the serum kinetic variation of a matrix metalloproteinase cluster].
    Frenoux C; Rebischung C; Quesada JL; Mendosa C; Letoublon C; Trocmé C
    Bull Cancer; 2018 Oct; 105(10):884-895. PubMed ID: 30243479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    Peltonen R; Gramkow MH; Dehlendorff C; Osterlund PJ; Johansen JS; Isoniemi H
    PLoS One; 2020; 15(8):e0236569. PubMed ID: 32756596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.
    Dragutinović VV; Radonjić NV; Petronijević ND; Tatić SB; Dimitrijević IB; Radovanović NS; Krivokapić ZV
    Mol Cell Biochem; 2011 Sep; 355(1-2):173-8. PubMed ID: 21541674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum MMP-8, -9 and TIMP-1 in patients with hepatocellular carcinoma.
    Lempinen M; Lyytinen I; Nordin A; Tervahartiala T; Mäkisalo H; Sorsa T; Isoniemi H
    Ann Med; 2013 Nov; 45(7):482-7. PubMed ID: 23962148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    Wang Y; Wei Y; Huang J; Li X; You D; Wang L; Ma X
    BMC Cancer; 2024 Aug; 24(1):1065. PubMed ID: 39210344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors.
    Zeman M; Maciejewski A; Półtorak S; Kryj M
    Pol Przegl Chir; 2013 Jun; 85(6):333-9. PubMed ID: 23828415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) in the serum are associated with poor prognosis in HPV-negative squamous cell oropharyngeal cancer.
    Carpén T; Sorsa T; Jouhi L; Tervahartiala T; Haglund C; Syrjänen S; Tarkkanen J; Mohamed H; Mäkitie A; Hagström J; Mattila PS
    Cancer Immunol Immunother; 2019 Aug; 68(8):1263-1272. PubMed ID: 31240326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
    Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
    J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
    Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
    Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of matrix metalloproteinase 2 and 9 after hepatic radiofrequency ablation.
    Frich L; Bjørnland K; Pettersen S; Clausen OP; Gladhaug IP
    J Surg Res; 2006 Oct; 135(2):297-304. PubMed ID: 16934296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
    Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
    Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer.
    Laitinen A; Hagström J; Mustonen H; Kokkola A; Tervahartiala T; Sorsa T; Böckelman C; Haglund C
    Tumour Biol; 2018 Sep; 40(9):1010428318799266. PubMed ID: 30192205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum MMP-14 predicts worse survival in gastric cancer.
    Kasurinen A; Tervahartiala T; Laitinen A; Kokkola A; Sorsa T; Böckelman C; Haglund C
    PLoS One; 2018; 13(12):e0208800. PubMed ID: 30532247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
    Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
    Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.